Le Lézard
Classified in: Health, Science and technology

MedShift Launches New Website, Cements Digital Footprint with New Modern Website


CHARLOTTE, N.C., Nov. 15, 2019 /PRNewswire-PRWeb/ -- Leading med-tech firm MedShift is proud to announce the launch of its reconceptualized website http://www.medshift.com. The new site features a modern design, enhanced functionality, and streamlined access to essential information to help medical practices and device developers navigate service offerings.

"The company has expanded rapidly since its inception and we needed a digital platform that could convey what we do in its totality," says Victoria Olszowy, Vice President of Communications & Marketing. "We are excited to debut the new site to our clients and partners who are seeking to appreciate the full breadth of MedShift's extensive portfolio."

The launch solidifies MedShift's brand and visual identity, clearly signaling the company's steps to scale up its business. The user-friendly design showcases a range of services across its satellites in the US, Australia, and New Zealand. For practices, the company features 12 leading aesthetic medical devices from eight manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers, MedShift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real time visibility, remote management, and big data modeling of entire medical device lineups.

MedShift CEO Brian Phillips remarks, "We view the new platform as just another way we're adding value across the manufacturer and provider spectrum. Our team thoroughly enjoyed thinking through how to communicate and implement the firm's story and we're excited to share the product of that work with our stakeholders."

As of today, the new site is fully operational and mobile-responsive. It will be continuously updated with the latest releases MedShift brings to the market. Visitors are encouraged to visit regularly to keep up with news of brand launches, product acquisitions and corporate milestones.

 

SOURCE MedShift


These press releases may also interest you

at 17:31
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...

at 17:26
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...

at 17:05
Antibe Announces TSX Delisting Review
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Toronto Stock Exchange ("TSX") is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Company's financial...

at 16:30
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Viatris Inc.  will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the...

at 16:30
WELL Health to Expand its Canadian Clinic Network with Acquisition from Shoppers Drug Mart Inc. of Medical Clinics operating as "The Health Clinic by Shopperstm"
WELL Health Clinic Network Inc. ("WELL"), a subsidiary of WELL Health Technologies Corp. , a digital healthcare company focused on...

at 16:25
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
Precision BioSciences, Inc. , an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain...

More news about Health...


News published on and distributed by: